Clinical Trials on SARS-CoV2 COVID-19

Total 8179 results

Imperial College Healthcare NHS Trust
Imperial College London; University of Oxford; Oxford University Hospitals NHS...

Withdrawn

SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations (SABRE)

Lymphoma | Leukemia | Immune Thrombocytopenia | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | Myeloma | Thrombotic Thrombocytopenic Purpura (TTP)

United Kingdom
Direction Centrale du Service de Santé des Armées

Completed

Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff (IMMUNO-COVID)

Sars-CoV2

France
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Active, not recruiting

CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms (CANDIDATE)

SARS-CoV2

Brazil
Ospedale San Raffaele

Unknown

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19) (COMBAT-19)

Covid-19 | Acute Respiratory Failure | ARDS, Human | Sars-CoV2 | Viral Pneumonia

Italy
Sahlgrenska University Hospital, Sweden

Active, not recruiting

COPE - COVID-19 in Pregnancy and Early Childhood (COPE)

Covid-19 | Pregnancy Complications | Sars-CoV2 | Pregnancy Preterm | Neonatal Infection | Pregnancy in Diabetic

Sweden
Johns Hopkins University
Rush University Medical Center; University of California, San Francisco; amfAR...

Completed

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

HIV | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)

United States
Szeged University

Unknown

Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19

COVID-19 | Sars-CoV2

Hungary
University Hospital, Lille

Completed

Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak (DolPsyCOVID)

Chronic Pain | Sars-CoV2

France
Turkish Intensive Care Society

Completed

Clinical Characteristics, Outcomes and Risk Factors for Mortality in Pregnant/Puerperal Women With COVID-19 Admitted to ICU in Turkey: a Multicenter, Retrospective Study From a Middle-income Country.

Key Words:COVID-19; Pregnancy; Intensive Care Unit; SARS-CoV-2; Mortality

Turkey
University of Chicago

Recruiting

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection (COVID-19)

COVID-19

United States
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection
Direction Centrale du Service de Santé des Armées

Recruiting

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics (COVOICE)

COVID-19 | Sars-CoV-2 Infection

France
Bioxytran Inc.

Not yet recruiting

To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M

COVID-19 | SARS CoV 2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

COVID-19 | SARS-CoV-2 Infection
Centre Hospitalier Régional d'Orléans

Recruiting

Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies (PNAS)

COVID-19 | SARS CoV 2 Infection

France
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz; Escola Nacional de Saúde Pública Sérgio Arouca... and other collaborators

Recruiting

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

SARS-CoV-2

Brazil
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Sinocelltech Ltd.

Not yet recruiting

To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19 (MAOP3)

COVID-19 | SARS-CoV-2
University of Zurich
Swiss School of Public Health (SSPH+)

Recruiting

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children (CiaoCorona)

COVID-19 | SARS-CoV 2

Switzerland
Assistance Publique - Hôpitaux de Paris

Recruiting

Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 (DEXDO-COVID)

SARS-CoV 2

France
Instituto de Investigación Marqués de Valdecilla
Hospital Universitario de Canarias; Hospital Universitario Marqués de Valdecilla and other collaborators

Recruiting

Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry (RegCOVID19)

SARS-CoV-2

Spain
Invivyd, Inc.

Active, not recruiting

A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2

COVID-19 | SARS-CoV-2

United States
Pfizer

Active, not recruiting

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

COVID-19 | SARS-CoV-2

Japan
ModernaTX, Inc.

Active, not recruiting

A Study of the Effectiveness of Moderna COVID-19 Vaccine

COVID-19 | SARS-CoV-2

United States
WestVac Biopharma Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster

COVID-19 | SARS-CoV-2 Infection

Mexico
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19 | SARS CoV 2 Infection

Australia
Atea Pharmaceuticals, Inc.

Active, not recruiting

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

COVID-19 | SARS CoV 2 Infection

United States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection

China
University of Cologne
Boehringer Ingelheim; ZKS Köln

Completed

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

SARS-CoV-2 Infection

Germany
BioNTech SE
Pfizer

Active, not recruiting

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States
NOWDiagnostics, Inc.

Completed

NOWDx Test for the Detection of Antibodies to COVID-19

COVID-19 | SARS-CoV-2 | Coronavirus

United States
Health Institutes of Turkey

Completed

Phase 3 Booster Vaccination Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Speransa Therapeutics

Terminated

A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins

SARS-CoV-2 Infection

United States, Germany
AstraZeneca
Iqvia Pty Ltd

Completed

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

COVID-19 | SARS-CoV-2

United States, Chile, Peru
Serap Yavuz
MDX Klinik Araştırma Egitim ve Danismanlik Ltd. Sti.

Active, not recruiting

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

COVID-19 | SARS-CoV-2 Infection

Turkey
Pfizer

Completed

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

SARS-CoV-2 Infection

United States
Mekelle University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Liverpool... and other collaborators

Completed

Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19) (Profile-Cov)

COVID-19 | SARS-CoV-2

Ethiopia
Montana State University
University of Washington; Fred Hutchinson Cancer Center; National Institute of... and other collaborators

Completed

Protecting Our Community: COVID-19 Testing

Covid19 | SARS-CoV-2

United States
Universiteit Antwerpen
University of Liege; Sciensano

Completed

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19) (CHARMING)

COVID-19 | SARS-CoV-2

Belgium
Health Institutes of Turkey

Completed

Booster Vaccination Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
ACM Biolabs

Completed

Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

SARS-CoV-2 Infection

Australia
RSV Therapeutics LLC

Completed

A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19

SARS-CoV-2 Infection

Russian Federation
University of Minnesota

Completed

Evaluation of Point-of-Care (EPOC) for COVID-19 ((EPOC))

COVID-19 | SARS CoV 2 Infection

United States
AstraZeneca
Clalit Health Services

Completed

eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services (VALOR C19 IL)

COVID-19 | SARS-CoV-2

Israel
Quratis Inc.

Active, not recruiting

Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)

COVID-19 | SARS-CoV-2

Korea, Republic of
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.

SARS-CoV-2

China
University of Melbourne
Southern Star Research Pty Ltd.

Completed

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

SARS-CoV-2

Australia
Prisma Health-Upstate

Completed

COVID-19 on Placental Gene Expression and Pathology (PROSPER)

COVID-19 | SARS-CoV-2 Infection

United States
Swansea University
Cardiff University; Abertawe Bro Morgannwg University Health Board; Marinomed... and other collaborators

Completed

Carrageenan Nasal Spray for COVID-19 Prophylaxis (ICE-COVID)

COVID-19 | SARS-CoV 2

United Kingdom

Clinical Trials on SARS-CoV2 COVID-19

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations